SARCOPENIA – CAUSES AND MANAGEMENT

Vladimir Antić, Milorad Antić

DOI Number
https://doi.org/10.22190/FUMB250129007A
First page
Last page

Abstract


Sarcopenia is an epidemic that has been recognized only recently, presenting a threat to the functional independence and quality of life of the elderly. Sarcopenia is defined as a loss of muscle mass in combination with changes in muscle quality and physical function. Common causes of sarcopenia are the aging process, an imbalance of sex hormones, lack of physical activity or chronic diseases, which is why sarcopenia, apart from the elderly, can also occur in the younger population. Both dimensions of sarcopenia, quantitative, skeletal muscle loss, and qualitative, loss of quality of life and disability, should be considered when creating and designing preventive and therapeutic measures. There are quick and simple tests for the diagnosis of sarcopenia, but they are still not sufficiently recognized and regularly used as part of physiotherapy assessment.

Keywords

Sarcopenia, Muscle mass, Muscle streght, Aging

Full Text:

PDF

References


Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127(5 Suppl):990S-991S.

Morley JE. Sarcopenia in the elderly. Fam Pract 2012; 29(Suppl 1):i44-i48.

Narici MV, Maffuli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 2010; 93:139-159.

Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393(10191):2636-2646.

Clark BC, Manini TM. What is dynapenia? Nutrition 2012; 28(5):495-503.

Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med 2004; 59(3):255-263.

Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008; 9(8):545-551.

Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 2003; 58(10):M911-M916.

Thompson DD. Aging and sarcopenia. J Musculosceletal Neuronal Interact 2007; 7(4):344-345.

Menant JC, Weber F, Lo J, et al. Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia? Osteoporos Int 2017; 28(1):59-70.

Manini TM, Clark BC. Dynapenia and aging: An Update. J GerontolABiol Sci Med Sci 2012; 67(1):28-40.

Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48(1):16–31.

Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016; 7(5):512–514.

Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50(5):889-896.

Janssen I. Evolution of sarcopenia research. Appl Phsyiol Nutr Metab 2010; 35(5):707-712.

Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12(7):433-450.

von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 2010; 1(2):129–133.

Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001; 137(4):231–243.

Keller K, Coldewey M, Engelhardt M. Muscle mass and strength loss with aging. Gazz Med Ital Arch Sci Med 2014; 173(9):477–483.

Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2022; 13(1):86-99.

Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med 2011; 27(3):355-363.

Antić V. Morfometrijska i imunohistohemijska analiza somatotropnih ćelija adenohipofize i njihova povezanost sa prisustvom sarkopenije tokom starenja čoveka. Doktorska disertacija. Niš: Medicinski fakultet; 2015.

Goodpaster BH, Park SW, Harris TB, et al. The loss of sceletal strength mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61(10):1059-1064.

Verdijk LB, Snijders T, Beelen M, et al. Characheristics of muscle fibers type are predictive of sceletal muscle mass and strengh of elderly men. J Am Geriatr Soc 2010; 58(11):2069-2075.

Keller K. Sarcopenia. Wien Med Wochenschr 2019; 169: 157–172.

Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y. Sarcopenia. Joint Bone Spine 2019; 86(3):309-314.

Cai L, Shi L, Peng Z, Sun Y, Chen J. Ageing of skeletal muscle extracellular matrix and mitochondria: finding a potential link. Ann Med 2023; 55(2):2240707.

Marzetti E, Calvani R, Tosato M, et al; SPRINTT Consortium. Sarcopenia: an overview. Aging Clin Exp Res 2017; 29(1):11-17.

Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol (1985) 2003; 95(4):1717-1127.

Lexell J. Evidence for nervous system degeneration with advancing age. J Nutr 1997; 127(5 Suppl):1011S-1013S.

Ling SM, Conwit RA, Ferrucci L, Metter EJ. Age-associated changes in motor unit physiolgy: observation from the Baltimore Longitudinal Study of Aging. Arch Phys Med Rehabil 2009; 90(7):1237-1240.

Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve 2002; 25(1):17-25.

Roth SM, Ivey FM, Martel GF, et al. Muscle size responses to stren- ght training in young and older men and women. J Am Geriatr Soc 2001; 49(11):1428-1433.

Roubenoff R. Origins and clinical relevance of sarcopenia. Can J Appl Physiol 2001; 26(1):78-89.

Rodríguez Cruz PM, Cossins J, Beeson D, Vincent A. The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis. Front Mol Neurosci 2020; 13:610964.

Wang Q, Cui C, Zhang N, et al. Effects of physical exercise on neuromuscular junction degeneration during ageing: A systematic review. J Orthop Translat 2024; 46:91-102.

Monti E, Tagliaferri S, Zampieri S, et al. Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function. J Cachexia Sarcopenia Muscle 2023; 14(2):794-804.

Cacciatore S, Calvani R, Esposito I, et al. Emerging Targets and Treatments for Sarcopenia: A Narrative Review Nutrients 2024; 16(19):3271.

Ueta R, Sugita S, Minegishi Y, et al. DOK7 Gene Therapy Enhances Neuromuscular Junction Innervation and Motor Function in Aged Mice. iScience 2020; 23(8):101385.

Ozes B, Tong L, Myers M, Moss K, Ridgley A, Sahenk Z. AAV1.NT-3 gene therapy prevents age-related sarcopenia. Aging (Albany NY). 2023; 15(5):1306-1329.

Xhuti D, Nilsson MI, Manta K, Tarnopolsky MA, Nederveen JP. Circulating exosome-like vesicle and skeletal muscle microRNAs are altered with age and resistance training. J Physiol 2023; 601(22):5051-5073.

Aoi W, Tanimura Y. Roles of Skeletal Muscle-Derived Exosomes in Organ Metabolic and Immunological Communication. Front Endocrinol (Lausanne) 2021; 12:697204.

Wan R, Liu S, Feng X, et al. The Revolution of exosomes: From biological functions to therapeutic applications in skeletal muscle diseases. J Orthop Translat 2024; 45:132-139.

Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 2004; 7(4):405-410.

Marcell TJ, Harman SM, Urban RJ, Metz DD, Rodgers BD, Blackman MR. Compa rison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. Am J Physiol Endocrinol Metab 2001; 281(6):E1159-E1164.

Kamel H, Maas D, Duthie E. Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging 2002; 19(11):865-877.

Haren MT, Siddiqui AM, Armbrecht HJ, et al. Testosterone modulates gene expre- ssion pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. Int J Androl 2011; 34(1):55-68.

Gentili A, Mulligan T, Godschalk M, et al. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab 2002; 87(2):825-834.

Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159(5):507-514.

Tiidus PM. Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies. Eurasian J Med 2011; 43(2):109-114.

Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 2014; 33(5):737-748.

Payette H, Roubenoff R, Jacques PF, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old commu- nity-living men and women: the Framingham Heart Study. J Am Geriatr Soc 2003; 51 (9):1237-1243.

Roubenoff R, Parise H, Payette HA, et al. Cytocines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Hearth Study. Am J Med 2003; 115(6):429-435.

Morley JE. Anabolic steroids and frailty. J Am Med Dir Assoc 2010; 11(8):533-536.

Phu S, Boersma D, Duque G. Exercise and Sarcopenia. J Clin Densitom. 2015; 18(4):488-492.

Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D Deficiency and Sarcopenia in Older Persons. Nutrients 2019; 11(12): 2861.

Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Calcif Tissue Int 2013; 92(2):151–162.

Coen PM, Musci RV, Hinkley JM, Miller BF. Mitochondria as a Target for Mitigating Sarcopenia. Front Physiol 2019; 9:1883.

Thomas DT, Schnell DM, Redzic M, et al. Local In Vivo Measures of Muscle Lipid and Oxygen Consumption Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older Adults. Nutrients 2019; 11(4):930.

Uchitomi R, Oyabu M, Kamei Y. Vitamin D and Sarcopenia: Potential of Vitamin D Supplementation in Sarcopenia Prevention and Treatment. Nutrients 2020; 12(10):3189.

van der Wielen R, Lowik M, Van den Berg. Serum vitamin D concetrations among eldery people in Europe. Lancet 1995; 346(8969):207-210.

Paddon-Jones D, Sheffield-Moore M, Zhang XJ, et al. Amino-acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab 2004; 286(3):E321-E328.

Strasser B, Ticinesi A. Intestinal microbiome in normal ageing, frailty and cognition decline. Curr Opin Clin Nutr Metab Care 2023; 26(1):8-16.

Rashidah NH, Lim SM, Neoh CF, et al. Differential gut microbiota and intestinal permeability between frail and healthy older adults: A systematic review. Ageing Res Rev 2022; 82:101744.

Ghosh TS, Shanahan F, O'Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol 2022; 19(9):565-584.

Wilmanski T, Diener C, Rappaport N, et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab 2021; 3(2):274-286.

Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin hevy-chain and sarcoplasmic protein in hu mans. Am J Physiol 1997; 273(4 Pt 1):E790-E800.

Lissett CA, Shalet SM. Effects of growth hormone on bone and muscle. Growth Horm IGF Res 2000; 10(Suppl. B):S95-S101.

Morley JE. Weight loss in older presons: new therapeutic approaches. Cur Pharm Des 2007; 13(35):3637-3647.

Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but non functional ability. Ann Intern Med 1996; 124(8):708-716.

Blackman MR, Sorkin JD, Münzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002; 288(18):2282-2292.

Bartke A. The somatotropic axis and aging: mechanisms and persistent questions about practical implications. Exp Gerontol 2009; 44(6-7):372-374.

Lord C, Chaput JP, Aubertin-Leheudre M, Labonté M, Dionne IJ. Dietary animal protein intake: association with muscle mass index in older women. J Nutr Health Aging 2007; 11(5):383-387.

Campbell WW, Trappe TA, Wolfe RR, Evans WJ. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci 2001; 56(6):M373-M380.

Zeng D, Ling XY, Fang ZL, Lu YF. Optimal exercise to improve physical ability and performance in older adults with sarcopenia: a systematic review and network meta-analysis. Geriatr Nurs 2023; 52:199-207.

Latham NK, Bennett DA, Stretton CM, Anderson CS. Systematic review of progressive resistence strenght traing in older adults. J Gerontol A Biol Sci Med Sci 2004; 59 (1):48-61.

Bean JF, Kiely DK, LaRose S, O'Neill E, Goldstein R, Frontera WR. Increased velocity exercise specific to task training versus the National Institute on Aging's strength training program: changes in limb power and mobility. J Gerontol A Biol Sci Med Sci 2009; 64(9):983-991.

Hazell T, Kenno K, Jacobi J. Functional benefit of power training for older adults. J Aging Phys Act 2007; 15(3):349-359.

Sayers SP. High-speed power traing: a novel approach to resistance traing in older men and women. A brief review and pilot study. J Strenght Cond Res 2007; 21(2): 518-528.

Miszko TA, Cress ME, Slade JM, Covey CJ, Agrawal SK, Doerr CE. Effect of stren ght and power training on physical function in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2003; 58(2):171-175.

Reid KF, Callahan DM, Carabello RJ, Phillips EM, Frontera WR, Fielding RA. Lower extremity power training in elderly subjects with mobility limitations: a. randomized controlled trial. Aging Clin Exp Res 2008; 20(4):337-343.

Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002; 13(5):561-568.

Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000; 55(12):M709-M715.

Klitgaard H, Mantoni M, Schiaffino S, et al. Functional, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 1990; 140(1):41-54.

Sheffield-Moore M, Yeckel CW, Volpi E, et al. Postexercise protein metabolism in older and younger men following moderate-intensity aerobic exercise. Am J Physiol Endocrinol Metab 2004; 287(3):E513-E522.

Tracy BL, Ivey FM, Hurlbut D, et al. Muscle quality. II. Effects Of strength training in 65- to 75-yr-old men and women. J Appl Physiol (1985) 1999; 86(1):195-201.




DOI: https://doi.org/10.22190/FUMB250129007A

Refbacks

  • There are currently no refbacks.


© University of Niš, Serbia
Creative Commons licence CC BY-NC-ND
ISSN 0354-4699 (Print)
ISSN 2406-050X (Online)